| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.21 | 4e-05 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0009 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.096 | 0.003 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |